Topic
Every article tagged “Depression”, newest first.
248 articles · page 4 of 7 · Jan 28, 2026 – Mar 9, 2026
Archive summary Clinical
The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new warnings to…
Archive summary Clinical
A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the earliest damage in diabetic retinopathy by…
Archive summary Clinical
People living with depression cannot just get over it. They need support, healing, and to discover the epicenter of their pain.
Archive summary Clinical
Top FDA regulator Dr. Tracy Beth Hoeg is accused of bypassing standard recusal rules to advance a friend's push for new antidepressant warning labels.
Archive summary Clinical
WASHINGTON — The Food and Drug Administration's top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new…
Archive summary Clinical
The antidepressant review is the latest in a series of controversial topics taken up by Hoeg.
Archive summary Clinical
Archive summary Clinical
A newly FDA-cleared treatment for major depressive disorder significantly accelerates symptom relief compared to traditional therapies. Accelerated Deep TMS (SWIFT) uses…
Archive summary Clinical
The FDA has approved zuranolone as the first oral medication indicated to treat postpartum depression (PPD), affecting 10-20 percent of new mothers. The medication…
Archive summary Clinical
Israeli biopharma company PsyRx is developing an innovative combination drug to address treatment-resistant depression (TRD), one of the most significant challenges in…
Archive summary Clinical
Depression affects approximately 5% of adults worldwide, and treatment-resistant depression represents a significant clinical challenge. About one-third of people with…
Archive summary Clinical
Archive summary Clinical
They’re prominent talking points for Health Secretary Robert F. Kennedy Jr.
Archive summary Clinical
They’re prominent talking points for Health Secretary Robert F. Kennedy Jr. and his top officials: Taking Tylenol while pregnant could be linked to autism.…
Archive summary Clinical
A large review adds weight to an old idea: movement can help ease depression. Here’s how to think about exercise as part of treatment and recovery.
Archive summary Clinical
Key findings at a glance: A recent study evaluated 600 adults with depression. Over 80% of participants experienced significant symptom improvement with a novel ...
Archive summary Clinical
Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with effects lasting up to six months.
Archive summary Clinical
Archive summary Clinical
Fathers may get postpartum depression at a similar rate to mothers, but it’s often overlooked. At last, the way we diagnose and treat it is improving, for the good of…
Archive summary Clinical
NRx Pharmaceuticals (NASDAQ: NRXP) announced completion of an in-person Type C guidance meeting with the U.S. Food and Drug Administration, attended by leadership ...
Archive summary Clinical
Archive summary Clinical
Archive summary Clinical
WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that it has…
Archive summary Clinical
Archive summary Clinical
A plant-based diet can do more than reduce our risk of physical disease. It may improve mood, and even reduce the risk of depression and anxiety, too.
Archive summary Clinical
Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator advancing toward IND-enabling studies for TRDHEIDELBERG, Germany, Feb.…
Archive summary Clinical
Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant reduction in depressive symptoms as ...
Archive summary Clinical
Findings provide rationale for targeted strategy in psychiatry that may lead to new personalized treatments for major depressive disorder and other conditions
Archive summary Clinical
Archive summary Clinical
This article has been disseminated on behalf of Helus Pharma and may include paid advertising.Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP), a clinical-stage ...
Archive summary Clinical
Antidepressant withdrawal reactions are now understood to be potentially more common, complex, severe, and long-lasting than previously acknowledged in clinical…
Archive summary Clinical
(NaturalNews) Long dismissed by conventional medicine, leaky gut (intestinal permeability) is now linked to autoimmune disorders, chronic inflammation and depre...
Archive summary Clinical
By Brittnee Bryant Star Correspondent Colder days and longer nights can leave individuals feeling depressed during the winter months. It’s a phenomenon known as Seasonal…
Archive summary Clinical
A study by researchers at King's College London analyzing data from more than 29 million individuals in England found that COVID-19 has had a lasting and…
Archive summary Clinical
(NaturalNews) A major scientific review concludes that physical exercise can be as effective as psychological therapies like cognitive behavioral therapy in all...
Archive summary Clinical
Archive summary Clinical
Flow Neuroscience announced FDA approval of its Flow at-home brain-stimulation device for treating major depressive disorder, marking the first time American clinicians…
Archive summary Clinical
Rejoyn, developed by Otsuka Precision Health in partnership with Click Therapeutics, is the first-and-only prescription digital therapeutic FDA-cleared for treating…
Archive summary Clinical
Solvonis Therapeutics PLC announced positive preclinical data for SVN-15, its lead compound positioned as a potential first-in-class depression treatment that targets…
Archive summary Clinical
Solvonis Therapeutics has announced promising preclinical trial data for its lead molecule, SVN-015, a potential breakthrough depression treatment. The compound has…